ZA976585B - Aprotinin variants having improved properties. - Google Patents

Aprotinin variants having improved properties.

Info

Publication number
ZA976585B
ZA976585B ZA9706585A ZA976585A ZA976585B ZA 976585 B ZA976585 B ZA 976585B ZA 9706585 A ZA9706585 A ZA 9706585A ZA 976585 A ZA976585 A ZA 976585A ZA 976585 B ZA976585 B ZA 976585B
Authority
ZA
South Africa
Prior art keywords
improved properties
aprotinin variants
aprotinin
variants
properties
Prior art date
Application number
ZA9706585A
Other languages
English (en)
Inventor
Werner Schroder
Soren Bjorn
Kjeld Norris
Viggo Diness
Leif Norkskov-Lauritsen
Niels Dyhr Christensen
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of ZA976585B publication Critical patent/ZA976585B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81Protease inhibitors
    • C07K14/8107Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8114Kunitz type inhibitors
    • C07K14/8117Bovine/basic pancreatic trypsin inhibitor (BPTI, aprotinin)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81Protease inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81Protease inhibitors
    • C07K14/8107Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8114Kunitz type inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ZA9706585A 1996-07-25 1997-07-24 Aprotinin variants having improved properties. ZA976585B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19629982A DE19629982A1 (de) 1996-07-25 1996-07-25 Aprotinin-Varianten mit verbesserten Eigenschaften

Publications (1)

Publication Number Publication Date
ZA976585B true ZA976585B (en) 1998-02-03

Family

ID=7800774

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9706585A ZA976585B (en) 1996-07-25 1997-07-24 Aprotinin variants having improved properties.

Country Status (37)

Country Link
US (2) US6482798B2 (cs)
EP (1) EP0821007B1 (cs)
JP (1) JPH10101700A (cs)
KR (1) KR980009283A (cs)
CN (1) CN1172116A (cs)
AR (1) AR008783A1 (cs)
AT (1) ATE260975T1 (cs)
AU (2) AU2870197A (cs)
BG (1) BG101787A (cs)
BR (1) BR9704068A (cs)
CA (1) CA2207071A1 (cs)
CO (1) CO4890857A1 (cs)
CZ (1) CZ236797A3 (cs)
DE (2) DE19629982A1 (cs)
DZ (1) DZ2276A1 (cs)
EE (1) EE9700177A (cs)
ES (1) ES2217350T3 (cs)
HN (1) HN1997000094A (cs)
HR (1) HRP970384A2 (cs)
HU (1) HUP9701290A3 (cs)
ID (1) ID17508A (cs)
IL (1) IL121361A0 (cs)
MA (1) MA24279A1 (cs)
NO (1) NO973426L (cs)
NZ (1) NZ328402A (cs)
PE (1) PE92298A1 (cs)
PL (1) PL321341A1 (cs)
RU (1) RU2197983C2 (cs)
SG (1) SG71714A1 (cs)
SK (1) SK101997A3 (cs)
SV (1) SV1997000068A (cs)
TN (1) TNSN97130A1 (cs)
TR (1) TR199700688A2 (cs)
TW (1) TW480271B (cs)
UA (1) UA55380C2 (cs)
YU (1) YU31697A (cs)
ZA (1) ZA976585B (cs)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19725014A1 (de) * 1997-06-13 1998-12-17 Bayer Ag Aprotininvarianten mit verbesserten Eigenschaften und Bikunine von Aprotininvarianten
US6974188B2 (en) * 2003-08-13 2005-12-13 Cosco Management, Inc. Chair with pivotable chair back
US20060218667A1 (en) * 2004-10-12 2006-09-28 Vojdani Fakhrieh S Plant-produced recombinant aprotinin and aprotinin variants
WO2006042327A2 (en) * 2004-10-12 2006-04-20 Large Scale Biology Corporation Plant-produced recombinant aprotinin and aprotinin variants
CN101160403B (zh) * 2005-02-18 2014-08-13 安吉奥开米公司 转运化合物穿过血脑屏障的分子
WO2008077478A1 (en) * 2006-12-22 2008-07-03 Bayer Schering Pharma Aktiengesellschaft Preparation and use of variants of the kunitz domain 2 of the human placental bikunin gene
WO2008110301A1 (de) * 2007-03-13 2008-09-18 Bayer Schering Pharma Aktiengesellschaft Aprotinin-varianten mit verbesserten eigenschaften
DE102007056231A1 (de) 2007-09-08 2009-03-12 Bayer Healthcare Ag Herstellung und Verwendung von Varianten humander Kunitz-Typ Protease-Inhibitoren (hKTPI)
BRPI1103921A2 (pt) 2011-08-17 2013-08-06 Mahle Metal Leve Sa camisa de cilindro e liga de ferro fundido

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU560584B2 (en) 1983-07-28 1987-04-09 Bayer Aktiengesellschaft Homologues of aprotinin
US4595974A (en) * 1984-09-10 1986-06-17 Burroughs Corporation Base drive circuit for a switching power transistor
GB2208511A (en) 1987-08-07 1989-04-05 Bayer Ag Variants of bovine pancreatic trypsin inhibitor produced by recombinant dna technology
DK225488D0 (da) * 1988-04-26 1988-04-26 Novo Industri As Polypeptid
US5591603A (en) 1987-08-28 1997-01-07 Novo Nordisk A/S Process for preparing aprotinin and aprotinin analogs in yeast cells
DK463887D0 (da) 1987-09-07 1987-09-07 Novo Industri As Gaerleader
DK105489D0 (da) 1989-03-03 1989-03-03 Novo Nordisk As Polypeptid
DE3930522A1 (de) * 1989-09-13 1991-03-21 Bayer Ag Rekombinante aprotinin-varianten - gentechnisches verfahren zur mikrobiellen herstellung von homogen prozessierten aprotinin-varianten sowie die therapeutische anwendung derselben
US5231010A (en) 1989-09-13 1993-07-27 Bayer Aktiengesellschaft Recombinant aprotinin variants genetically engineered process for the microbial preparation of homogeneously processed aprotinin variants and the therapeutic use thereof
IL99585A0 (en) * 1990-10-01 1992-08-18 Novo Nordisk As Aprotinin analogues,their production and pharmaceutical compositions containing them
WO1994001461A1 (en) * 1992-07-13 1994-01-20 Corvas International, Inc. BOVINE PANCREATIC TRYPSIN INHIBITOR DERIVED INHIBITORS OF FACTOR Xa
KR100199565B1 (ko) * 1994-08-19 1999-06-15 차동천 승화형 감열전사 기록용 수용지의 중간층 제조방법

Also Published As

Publication number Publication date
DE59711356D1 (de) 2004-04-08
RU2197983C2 (ru) 2003-02-10
YU31697A (sh) 1999-07-28
CO4890857A1 (es) 2000-02-28
EE9700177A (et) 1998-02-16
EP0821007A3 (de) 1998-11-18
HN1997000094A (es) 1997-12-26
AU5178701A (en) 2001-09-06
SK101997A3 (en) 1998-03-04
ID17508A (id) 1998-01-08
PE92298A1 (es) 1999-02-13
NO973426L (no) 1998-01-26
MA24279A1 (fr) 1998-04-01
DE19629982A1 (de) 1998-01-29
US20020103334A1 (en) 2002-08-01
US20030096752A1 (en) 2003-05-22
AU762041B2 (en) 2003-06-19
BG101787A (en) 1998-10-30
IL121361A0 (en) 1998-01-04
HU9701290D0 (en) 1997-09-29
NZ328402A (en) 1999-03-29
MX9705605A (es) 1998-08-30
AU2870197A (en) 1998-02-05
CN1172116A (zh) 1998-02-04
TR199700688A2 (xx) 1998-02-21
SV1997000068A (es) 1998-07-09
ES2217350T3 (es) 2004-11-01
BR9704068A (pt) 1999-01-05
TNSN97130A1 (fr) 2005-03-15
EP0821007B1 (de) 2004-03-03
AR008783A1 (es) 2000-02-23
CA2207071A1 (en) 1998-01-25
HUP9701290A2 (hu) 1999-06-28
SG71714A1 (en) 2000-04-18
TW480271B (en) 2002-03-21
HRP970384A2 (en) 1998-04-30
PL321341A1 (en) 1998-02-02
EP0821007A2 (de) 1998-01-28
CZ236797A3 (cs) 1998-02-18
DZ2276A1 (fr) 2002-12-18
JPH10101700A (ja) 1998-04-21
UA55380C2 (uk) 2003-04-15
KR980009283A (ko) 1998-04-30
US6482798B2 (en) 2002-11-19
HUP9701290A3 (en) 2000-08-28
NO973426D0 (no) 1997-07-24
ATE260975T1 (de) 2004-03-15

Similar Documents

Publication Publication Date Title
ZA9710429B (en) Broad-spectrumδ-endotoxins.
ZA979199B (en) Aminothiophenecarboxamides.
ZA976168B (en) 3-Ureido-pyridofurans and -pyridothiophenes.
ZA974523B (en) Endoscopes.
ZA978178B (en) Composition.
PL327037A1 (en) Novel combination
ZA977206B (en) Arylalkanoylpyridazines.
ZA975261B (en) Composition.
ZA978304B (en) 3-alkyl-3-phenyl-piperidines.
ZA974527B (en) Selector assembly.
DE69723848D1 (en) 3-descladinose-2,3-anhydroerythromycin-derivate
ZA981926B (en) Detergent--package combination.
ZA972131B (en) Stabilizer combination.
ZA975742B (en) Modified oligonucleotides.
GB2311033B (en) Combination part
ZA976585B (en) Aprotinin variants having improved properties.
PL332732A1 (en) Combination toy-candy
ZA97928B (en) Novel heteroaryl-oxazolidinones.
ZA97572B (en) 1-pyrazol-3-ylethyl-4-indol-3-ylpiperidines.
ZA974052B (en) New benzothiazolinones.
ZA976022B (en) Cycloalkano-pyridines.
ZA971466B (en) Endothelin-receptor-antagonists.
ZA974056B (en) New thiazolopyridines.
GB9623236D0 (en) Notch
ZA971474B (en) Endothelin-receptor-antagonists.